A Randomised Dose Escalation Study of Subcutaneous Interleukin 2 With and Without Levamisole in Patients With Metastatic Renal Cell Carcinoma or Malignant Melanoma

British Journal of Cancer - United Kingdom
doi 10.1038/bjc.1996.498
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC